208 related articles for article (PubMed ID: 15777236)
1. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
Marcinkiewicz C
Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
[TBL] [Abstract][Full Text] [Related]
2. Non-RGD-containing snake venom disintegrins, functional and structural relations.
Walsh EM; Marcinkiewicz C
Toxicon; 2011 Sep; 58(4):355-62. PubMed ID: 21801741
[TBL] [Abstract][Full Text] [Related]
3. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
4. Structure-function correlations of snake venom disintegrins.
Calvete JJ
Curr Pharm Des; 2005; 11(7):829-35. PubMed ID: 15777237
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
7. From Snake Venom's Disintegrins and C-Type Lectins to Anti-Platelet Drugs.
Lazarovici P; Marcinkiewicz C; Lelkes PI
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31137917
[TBL] [Abstract][Full Text] [Related]
8. Disintegrins.
McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
[TBL] [Abstract][Full Text] [Related]
9. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Kuo YJ; Chung CH; Huang TF
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
[TBL] [Abstract][Full Text] [Related]
10. Applications of snake venom components to modulate integrin activities in cell-matrix interactions.
Marcinkiewicz C
Int J Biochem Cell Biol; 2013 Sep; 45(9):1974-86. PubMed ID: 23811033
[TBL] [Abstract][Full Text] [Related]
11. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
[TBL] [Abstract][Full Text] [Related]
12. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
[TBL] [Abstract][Full Text] [Related]
13. The First Snake Venom KTS/Disintegrins-Integrin Interactions Using Bioinformatics Approaches.
Khamessi O; Ben Mabrouk H; Kamoun S; Hkimi C; Ghedira K; Kharrat R
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615520
[TBL] [Abstract][Full Text] [Related]
14. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
15. Snake venoms and the hemostatic system.
Markland FS
Toxicon; 1998 Dec; 36(12):1749-800. PubMed ID: 9839663
[TBL] [Abstract][Full Text] [Related]
16. The continuing saga of snake venom disintegrins.
Calvete JJ
Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
[TBL] [Abstract][Full Text] [Related]
17. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.
Calvete JJ; Moreno-Murciano MP; Theakston RD; Kisiel DG; Marcinkiewicz C
Biochem J; 2003 Jun; 372(Pt 3):725-34. PubMed ID: 12667142
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
Okuda D; Morita T
J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
[TBL] [Abstract][Full Text] [Related]
19. [Potential use of snake venom components in cancer treatment].
Vivas D; Inga R; Yarlequé A
Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.
Brown MC; Eble JA; Calvete JJ; Marcinkiewicz C
Biochem J; 2009 Jan; 417(1):95-101. PubMed ID: 18774946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
